Literature DB >> 31864206

Image-based screening for men at high risk for breast cancer: Benefits and drawbacks.

Ryan W Woods1, Lonie R Salkowski2, Mai Elezaby3, Elizabeth S Burnside3, Roberta M Strigel4, Amy M Fowler4.   

Abstract

Male breast cancer is a rare malignancy. Due to low prevalence and limited data to support male breast cancer screening, there are currently no recommendations for image-based screening in asymptomatic men and few recommendations for men at high risk for breast cancer. However, symptomatically diagnosed cancers in men are typically advanced, suggesting that earlier detection may improve outcomes. In this article we briefly review the risk factors for male breast cancer, and discuss the potential benefits and possible drawbacks of routine image-based screening for men at high risk for breast cancer.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BRCA 1, 2; Male breast cancer; Mammography; Risk factors; Screening

Mesh:

Year:  2019        PMID: 31864206      PMCID: PMC7242122          DOI: 10.1016/j.clinimag.2019.11.005

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  70 in total

1.  Lumpectomy in male patients with breast cancer.

Authors:  Sharon H Giordano
Journal:  Ann Surg Oncol       Date:  2013-08       Impact factor: 5.344

2.  Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.

Authors:  Harvey A Risch; John R McLaughlin; David E C Cole; Barry Rosen; Linda Bradley; Isabel Fan; James Tang; Song Li; Shiyu Zhang; Patricia A Shaw; Steven A Narod
Journal:  J Natl Cancer Inst       Date:  2006-12-06       Impact factor: 13.506

3.  The diagnostic accuracy of mammography in the evaluation of male breast disease.

Authors:  G F Evans; T Anthony; R H Turnage; T D Schumpert; K R Levy; R H Amirkhan; T J Campbell; J Lopez; A H Appelbaum
Journal:  Am J Surg       Date:  2001-02       Impact factor: 2.565

4.  Gender differences in breast cancer: analysis of 13,000 breast cancers in men from the National Cancer Data Base.

Authors:  Jon M Greif; Christopher M Pezzi; V Suzanne Klimberg; Lisa Bailey; Marlene Zuraek
Journal:  Ann Surg Oncol       Date:  2012-07-06       Impact factor: 5.344

5.  Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study.

Authors:  Anthony J Swerdlow; Minouk J Schoemaker; Craig D Higgins; Alan F Wright; Patricia A Jacobs
Journal:  J Natl Cancer Inst       Date:  2005-08-17       Impact factor: 13.506

Review 6.  Male breast cancer.

Authors:  Ian S Fentiman; Alain Fourquet; Gabriel N Hortobagyi
Journal:  Lancet       Date:  2006-02-18       Impact factor: 79.321

7.  Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer.

Authors:  Wendie A Berg; Jeffrey D Blume; Jean B Cormack; Ellen B Mendelson; Daniel Lehrer; Marcela Böhm-Vélez; Etta D Pisano; Roberta A Jong; W Phil Evans; Marilyn J Morton; Mary C Mahoney; Linda Hovanessian Larsen; Richard G Barr; Dione M Farria; Helga S Marques; Karan Boparai
Journal:  JAMA       Date:  2008-05-14       Impact factor: 56.272

Review 8.  Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk?

Authors:  Suzanne B Coopey; Kinyas Kartal; Clara Li; Adam Yala; Regina Barzilay; Heather R Faulkner; Tari A King; Francisco Acevedo; Judy E Garber; Anthony J Guidi; Kevin S Hughes
Journal:  Breast Cancer Res Treat       Date:  2019-01-21       Impact factor: 4.872

9.  BRCA1 and BRCA2 mutations in a population-based study of male breast cancer.

Authors:  Victoria M Basham; Julian M Lipscombe; Joanna M Ward; Simon A Gayther; Bruce A J Ponder; Douglas F Easton; Paul D P Pharoah
Journal:  Breast Cancer Res       Date:  2001-11-21       Impact factor: 6.466

10.  Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?

Authors:  Peter D Beitsch; Pat W Whitworth; Kevin Hughes; Rakesh Patel; Barry Rosen; Gia Compagnoni; Paul Baron; Rache Simmons; Linda Ann Smith; Ian Grady; Michael Kinney; Cynara Coomer; Karen Barbosa; Dennis R Holmes; Eric Brown; Linsey Gold; Patricia Clark; Lee Riley; Samuel Lyons; Antonio Ruiz; Sadia Kahn; Heather MacDonald; Lisa Curcio; Mary Kay Hardwick; Shan Yang; Ed D Esplin; Robert L Nussbaum
Journal:  J Clin Oncol       Date:  2018-12-07       Impact factor: 44.544

View more
  6 in total

1.  Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Authors:  Valentina Silvestri; Goska Leslie; Daniel R Barnes; Bjarni A Agnarsson; Kristiina Aittomäki; Elisa Alducci; Irene L Andrulis; Rosa B Barkardottir; Alicia Barroso; Daniel Barrowdale; Javier Benitez; Bernardo Bonanni; Ake Borg; Saundra S Buys; Trinidad Caldés; Maria A Caligo; Carlo Capalbo; Ian Campbell; Wendy K Chung; Kathleen B M Claes; Sarah V Colonna; Laura Cortesi; Fergus J Couch; Miguel de la Hoya; Orland Diez; Yuan Chun Ding; Susan Domchek; Douglas F Easton; Bent Ejlertsen; Christoph Engel; D Gareth Evans; Lidia Feliubadalò; Lenka Foretova; Florentia Fostira; Lajos Géczi; Anne-Marie Gerdes; Gord Glendon; Andrew K Godwin; David E Goldgar; Eric Hahnen; Frans B L Hogervorst; John L Hopper; Peter J Hulick; Claudine Isaacs; Angel Izquierdo; Paul A James; Ramunas Janavicius; Uffe Birk Jensen; Esther M John; Vijai Joseph; Irene Konstantopoulou; Allison W Kurian; Ava Kwong; Elisabetta Landucci; Fabienne Lesueur; Jennifer T Loud; Eva Machackova; Phuong L Mai; Keivan Majidzadeh-A; Siranoush Manoukian; Marco Montagna; Lidia Moserle; Anna Marie Mulligan; Katherine L Nathanson; Heli Nevanlinna; Joanne Ngeow; Liene Nikitina-Zake; Kenneth Offit; Edith Olah; Olufunmilayo I Olopade; Ana Osorio; Laura Papi; Sue K Park; Inge Sokilde Pedersen; Pedro Perez-Segura; Annabeth H Petersen; Pedro Pinto; Berardino Porfirio; Miquel Angel Pujana; Paolo Radice; Johanna Rantala; Muhammad U Rashid; Barak Rosenzweig; Maria Rossing; Marta Santamariña; Rita K Schmutzler; Leigha Senter; Jacques Simard; Christian F Singer; Angela R Solano; Melissa C Southey; Linda Steele; Zoe Steinsnyder; Dominique Stoppa-Lyonnet; Yen Yen Tan; Manuel R Teixeira; Soo H Teo; Mary Beth Terry; Mads Thomassen; Amanda E Toland; Sara Torres-Esquius; Nadine Tung; Christi J van Asperen; Ana Vega; Alessandra Viel; Jeroen Vierstraete; Barbara Wappenschmidt; Jeffrey N Weitzel; Greet Wieme; Sook-Yee Yoon; Kristin K Zorn; Lesley McGuffog; Michael T Parsons; Ute Hamann; Mark H Greene; Judy A Kirk; Susan L Neuhausen; Timothy R Rebbeck; Marc Tischkowitz; Georgia Chenevix-Trench; Antonis C Antoniou; Eitan Friedman; Laura Ottini
Journal:  JAMA Oncol       Date:  2020-08-01       Impact factor: 31.777

Review 2.  Male Breast Cancer: An Updated Review of Epidemiology, Clinicopathology, and Treatment.

Authors:  Guoliang Zheng; Jose Pablo Leone
Journal:  J Oncol       Date:  2022-05-24       Impact factor: 4.501

3.  Care of men with cancer-predisposing BRCA variants.

Authors:  Rachel Horton; Paul Pharoah; Judith Hayward; Anneke Lucassen
Journal:  BMJ       Date:  2021-10-14

Review 4.  An Update on the General Features of Breast Cancer in Male Patients-A Literature Review.

Authors:  Sinziana Ionescu; Alin Codrut Nicolescu; Marian Marincas; Octavia-Luciana Madge; Laurentiu Simion
Journal:  Diagnostics (Basel)       Date:  2022-06-26

5.  Clinical features and prevalence of Klinefelter syndrome in transgender individuals: A systematic review.

Authors:  Bonnie Liang; Ada S Cheung; Brendan J Nolan
Journal:  Clin Endocrinol (Oxf)       Date:  2022-04-15       Impact factor: 3.523

6.  Male Breast Cancer Review. A Rare Case of Pure DCIS: Imaging Protocol, Radiomics and Management.

Authors:  Daniele Ugo Tari; Luigi Morelli; Antonella Guida; Fabio Pinto
Journal:  Diagnostics (Basel)       Date:  2021-11-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.